Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private

BSE1618.75-39.1 (-2.36 %)

PREV CLOSE ( ) 1657.85

OPEN PRICE ( ) 1657.85

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 3174

TODAY'S LOW / HIGH ( )1610.90 1657.85

52 WK LOW / HIGH ( )900 1711.95

NSE1617.75-41.15 (-2.48 %)

PREV CLOSE( ) 1658.90

OPEN PRICE ( ) 1655.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1617.75 (117)

VOLUME 32866

TODAY'S LOW / HIGH( ) 1609.95 1658.80

52 WK LOW / HIGH ( )900.05 1725

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984

Management Info

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office

Address 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone 079-68138700

Email complianceofficer@concordbiotech.com

Website www.concordbiotech.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

15Apr Reply To Clarification Sought On Volu
We hereby submit that the company has disclosed all the material informa..

06Mar Concord Biotech informs about updates
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..

23Feb Concord Biotech gets GMP for unit II o
Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has com..

23Feb Concord Biotech gains on getting GMP f
Concord Biotech is currently trading at Rs. 1463.65, up by 23.40 points..

09Feb Concord Biotech informs about investor
Pursuant to Regulation 30 of Schedule III Part A of SEBI (Listing Obliga..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL
Net Profit	745.54
Gross Profit	1000.85
Operating Profit	1141.17
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE) 2377.00 (6.44%)	M.Cap ( in Cr)29930.39
Alkem Laboratories (BSE) 4899.45 (2.36%)	M.Cap ( in Cr)58580.27
Astrazeneca Pharma I (BSE) 5424.45 (1.70%)	M.Cap ( in Cr)13561.13
Dr. Reddy's Lab (BSE) 6349.95 (0.98%)	M.Cap ( in Cr)105928.76
Torrent Pharma (BSE) 2732.60 (2.20%)	M.Cap ( in Cr)92483.60

Shareholding Pattern

	PROMOTERS	44.08%
	NON-INSTITUTION	41.03%
	MUTUAL FUNDS/UTI	5.15%
	FI/BANKS/INSURANCE	2.88%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
DSP Healthcare Fund...	4.04
Edelweiss Recently ...	3.64
Baroda BNP Paribas ...	2.74
Invesco India Aggre...	1.95
Union Small Cap Fun...	1.63
Baroda BNP Paribas ...	1.62
UTI Healthcare Fund...	1.61

Risk Disclosures on Derivatives

Smart Quotes

CONCORD BIOTECH LTD.